Concurrent mediastinal B cell lymphoma and chronic myeloid leukemia with an unusually favorable response to chemotherapy

Leukemia and Lymphoma

Volumn 44, Issue 3, 2003, Pages 535-538

  Au, W Y ^a   Ma, S K ^a   Wan, T S ^a   Wang, E P ^b   Lau, T C M ^a   Kwong, Y L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b GRANTHAM HOSPITAL   (Hong Kong)

Author keywords

Chronic myeloid leukemia; Mediastinal B cell lymphoma; Philadelphia negative; Spontaneous remission

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; HYDROXYUREA; MYELOPEROXIDASE; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

AGED; ARTICLE; B CELL LYMPHOMA; BLOOD CELL COUNT; BONE MARROW EXAMINATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CHINESE; CHRONIC MYELOID LEUKEMIA; CYTOPENIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE REARRANGEMENT; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTOSIS; LOW DRUG DOSE; MEDIASTINUM CANCER; MIXED TUMOR; ONCOGENE; PATHOGENESIS; PHILADELPHIA 1 CHROMOSOME; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOUTHERN BLOTTING; VIRUS REACTIVATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLONE CELLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; HYDROXYUREA; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LEUKOCYTOSIS; LYMPHOMA, B-CELL; MEDIASTINAL NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; PREDNISOLONE; PROCARBAZINE; REMISSION INDUCTION; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 0037346935     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000038029     Document Type: Article

References (22)

1. Biernaux, C., Loos, M., Sels, A., Huez, G. and Stryckmans, P. (1995) "Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals", Blood 86(8), 3118-3122.
2. Bose, S., Deininger, M., Gora-Tybor, J., Goldman, J.M. and Melo, J.V. (1998) "The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease", Blood 92(9), 3362-3367.
3. Au, W.Y., Lie, A.K., Ma, S.K., Wan, T.S., Liang, R., Leung, Y.H. and Kwong, Y.L. (2001) "Philadelphia (Ph) chromosome-positive chronic myeloid leukaemia relapsing as Ph-negative leukaemia after allogeneic bone marrow transplantation", Br. J. Haematol. 114(2), 365-368.
4. Reeves, J.E., Robbins, B.A., Pankey, L.R., Elias, A.L. and Anderson, W.F. (1995) "The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report", Cancer 75(8), 2089-2092.
5. Kwong, Y.L. and Cheng, G. (1993) "Clonal nature of chronic neutrophilic leukemia", Blood 82(3), 1035-1036.
6. Au, W.Y., Chan, A.C. and Kwong, Y.L. (1999) "Isolated lymph node T lymphoblastic transformation of chronic myeloid leukemia during interferon treatment", Am. J. Hematol. 62(4), 256-258.
7. Acar, H., Ecirli, S., Gundogan, F., Bulay, O. and Acar, A. (1999) "Simultaneous occurrence of chronic myelogenous leukemia and non-Hodgkin lymphoma at diagnosis", Cancer Genet. Cytogenet. 108(2), 171-174.
8. Montefusco, E., Lo Coco, F., Burgio, V.L., Rondinelli, B., Di Giorgio, G., Mancini, M., Diverio, D., Andrioni, A., Avvisati, G. and Alimena, G. (1993) "Occurrence of a Ki-1-positive anaplastic large-cell lymphoma in a patient with Ph-positive chronic myelogenous leukemia successfully treated by alpha-interferon", Leukemia 7(11), 1896-1899.
9. Ichinohasama, R., Miura, I., Takahashi, N., Sugawara, T., Tamate, E., Endoh, K., Naganuma, H., DeCoteau, J.F., Griffin, J.D., Kadin, M.E. and Ooya, K. (2000) "Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature", Leukemia 14(1), 169-182.
10. Verneris, M.R., Tuel, L. and Seibel, N.L. (1995) "Pediatric HIV infection and chronic myelogenous leukemia", Pediatr AIDS HIV Infect. 6(5), 292-294.
11. Vey, N., Camerlo, J., Xerri, L., Petit, N., Dermeche, S. and Maraninchi, D. (2001) "Simultaneous occurrence of kaposi's sarcoma and chronic myelogenous leukemia", Leuk. Lymphoma 41(3-4), 425-428.
12. Johnson, R.J., Owen, R.G., Child, J.A., Morgan, G.J., Barnard, D.L., Dickinson, H., Ricketts, S., Rawston, A., Evans, P., Woodhead, V., Major, K., Robinson, F. and Smith, G.M. (1996) "Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim)", Br. J. Haematol. 93(4), 863-868.
13. Mandigers, C.M., Mensink, E.J., Geurts van Kessel, A., van der Plas, D.C., Haanen, C., Hagemeyer, A. and de Witte, T. (1996) "A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone", Ann. Hematol. 72(6), 371-373.
14. Jankovic, G.M., Bogdanovic, A.D., Colovic, M.D., Novak, A.V., Andolina, M. and Anagnostopoulos, A. (1996) "Implications of prominent cytologic dysplasia persisting in the marrow of a patient with CML even after the spontaneous disappearance of the Philadelphia chromosome", Am. J. Hematol. 52(3), 234-235.
15. Fegan, C., Morgan, G. and Whittaker, J.A. (1989) "Spontaneous remission in a patient with chronic myeloid leukaemia", Br. J. Haematol. 72(4), 594-595.
16. Cagirgan, S., Sencan, M., Tombuloglu, M., Ozdemir, E., Hekimgil, M. and Buyukkececi, F. (1998) "Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia", Leuk. Lymphoma 29(3-4), 423-425.
17. Selleri, L., Emilia, G., Temperani, P., Grassilli, E., Zucchini, P., Tagliafico, E., Bonati, A., Venezia, L., Ferarri, S. and Torelli, U. (1989) "Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival", Leukemia 3(7), 538-542.
18. Prischl, F.C., Haas, O.A., Lion, T., Eyb, R. and Schwarzmeier, J.D. (1989) "Duration of first remission as an indicator of long-term survival in chronic myelogenous leukaemia", Br. J. Haematol. 71(3), 337-342.
19. Aviram, A., Blickstein, D., Stark, P., Luboshitz, J., Bairey, O., Prokocimer, M. and Shaklai, M. (1999) "Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients", Leuk. Lymphoma 33(1-2), 77-82.
20. Blickstein, D., Aviram, A., Luboshitz, J., Prokocimer, M., Stark, P., Bairey, O., Sulkes, J. and Shaklai, M. (1997) "BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation", Blood 90(7), 2768-2771.
21. Sokal, J.E., Cox, E.B., Baccarani, M., Tura, S., Gomez, G.A., Robertson, J.E., Tso, C.Y, Braun, T.J., Clarkson, B.D. and Cervantes, F. (1984) "Prognostic discrimination in 'good-risk' chronic granulocytic leukemia", Blood 63(4), 789-799.
22. Hasford, J., Pfirrmann, M., Hehlmann, R., Allan, N.C., Baccarani, M., Kluin-Nelemans, J.C., Alimena, G., Steegmann, J.L. and Ansari, H. (1998) "A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group", J. Natl Cancer Inst. 90(11), 850-858.